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An Alzheimer's Disease-Linked PS1 Variant
Rescues the Developmental Abnormalities
of PS1-Deficient Embryos
encoding amyloid precursor protein (APP) (Goate et al.,
1991; Chartier-Harlin et al., 1991; Naruse et al., 1991;
Hendriks et al., 1992; Mullan et al., 1992), presenilin 1
(PS1) (St. George-Hyslop et al., 1992; Alzheimer's Dis-
ease Collaborative Group, 1995; Campion et al., 1995;
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Baltimore, Maryland 21205 polytopic membrane proteins that are endoproteolyti-
5Mayo Clinic Jacksonville cally processed in vivo (Thinakaran et al., 1996). PSs
Jacksonville, Florida 32224 are homologous to sel-12, a C. elegans protein that
facilitates Notch/lin-12 signaling and cell-fate specifica-
tion during development (Levitan and Greenwald, 1995;
Summary Artavanis-Tsakonas et al., 1995). In nematodes, egg-
laying (Egl) defects associated with loss of sel-12 are
Mutations in presenilin1 (PS1)cosegregate with z25% efficiently rescued by human PS1 and PS2 (Levitan et
of early onset familial Alzheimer's disease (FAD) pedi- al., 1996; Baumeister et al., 1997), indicating that the
grees. A variety of in vitro and in vivo paradigms have homologous proteins are functionally interchangeable
established that one mechanism by which PS1 vari- in this system. Notably, several FAD-linked mutant PS1s
ants cause AD is by elevating the production of highly only partially rescue the Egl phenotype (Levitan et al.,
amyloidogenic Ab1±42/43 peptides. PS1 is homolo- 1996; Baumeister et al., 1997).
gous to sel-12, a C. elegans protein that facilitates To test directly the function of wild-type and mutant
signaling mediated by theNotch/lin-12 family of recep- human PS1 in mammals, we examined the ability of
tors. Wild-type human PS1 complements an egg-lay- these polypeptides to rescue the embryonic lethality
ing defect in C. elegans lacking sel-12, while FAD- and patterning defects in the axial skeleton of mice lack-
linked PS1 variants exhibit reduced rescue activity. ing PS1 (PS12/2 mice) (Shen et al. 1997; Wong et al.,
These data suggested that mutant PS1 may cause 1997). We now document that the deficiencies observed
disease as a result of reduction in PS1 function. To in the PS12/2 embryos are efficiently complemented
test the function of FAD-linked PS1 in mammals, we following expression of either wild-type human PS1
examined the ability of the A246E PS1 variant to com- (huPS1) or an FAD-linked PS1 variant (A246E). These
plement the embryonic lethality and axial skeletal de- findings provide support for the view that the A246E PS1
fects in mice lacking PS1. Finally, to examine the influ-
variant retains sufficient normal function for mammalian
ence of reduced PS1 levels on Ab production, we
embryonic development. Finally, and in view of the evi-
quantified Ab1±42/43 peptide levels in PS1 heterozy-
dence that FAD-linked mutant PS1 increases the extra-gous null mice (PS11/2 mice). We now report that both
cellular concentration of highly fibrillogenic Ab1±42/human wild-type and A246E PS1 efficiently rescue the
43 peptides (Borchelt et al., 1996; Duff et al., 1996;phenotypes observed in PS12/2 embryos, findings
Scheuner et al., 1996; Citron et al., 1997) and acceleratesconsistent with the view that FAD-linked PS1 mutants
Ab deposition in brains of transgenic mice (Borchelt etretain sufficient normal function during mammalian
al., 1997), we tested the hypothesis that PS1 variant-embryonic development. Moreover, the levels of Ab1±
mediated elevations in Ab1±42/43 levels during aging42/43 and Ab1±40 peptides between PS11/2 and con-
are the result of reduced PS1 function due to gene-trol mice are indistinguishable. Collectively, these data
dosage sensitivity. To address this issue, we generatedlead us to conclude that mutant PS1 causes AD not by
transgenic mice expressing a chimeric APP (APPswe)loss of normal PS1 function but by influencing amyloid
transgene (Borchelt et al., 1996) in a heterozygous nullprecursor protein (APP) processing in a manner that
(PS11/2) background. We chose this breeding strategyelevates Ab1±42/43 production.
to ensure that Ab1±40 and Ab1±42/43 peptides (derived
from the APPswe precursor) could be quantitativelyIntroduction
measured by sandwich ELISA (enzyme-linked immuno-
sorbent assay). We document that the levels of Ab1±42/Alzheimer's disease (AD), a progressive neurodegenera-
43 and Ab1±40 in the brains of young PS11/2 mice ex-tive disorder of late life, is characterized by the presence
pressing APPswe are not significantly different than theof senile plaques and neurofibrillary tangles in the hippo-
campus and cerebral cortex of affected individuals. Ap- Ab levels in PS11/1 mice expressing APPswe. Thus,
proximately 10% of cases of AD are familial (FAD); au- loss of a functional PS1 allele is insufficient to cause
tosomal dominant inheritance of mutations in genes elevations in Ab1±42/43 levels. We conclude that mutant
PS1 causes AD not by loss of normal function but by
influencing APP metabolism in a manner that elevates6 These authors contributed equally to this work.
7 To whom correspondence should be addressed. Ab1±42/43 production.
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Results
Accumulation of Human PS1 in the Presomitic
Mesoderm and Neural Tube of Transgenic
Mouse Embryos
We and others have documented that human PS1 and
PS2 efficiently rescued an egg-laying (Egl) deficit in C.
elegans lacking the PS homolog sel-12 (Levitan et al.,
1996; Baumeister et al., 1997). However, the rescue effi-
ciency of the tested FAD-linked human PS1 variants
was markedly diminished, a finding that supported the
view that mutant PS1 may cause AD as a result of re-
duced functional activity (Levitan et al., 1996; Baumeis-
ter et al., 1997). To test this hypothesis in mammals, we
assayed the activities of huPS1 or the FAD-linked A246E
PS1 variant by examining the ability of these molecules
to rescue the developmental deficits in PS12/2 mice,
which otherwise die during late embryogenesis or imme-
diately after birth; PS12/2 embryos exhibit abnormalities
in somite segmentation and loss of segment polarity
that lead to patterning defects in axial skeleton and
spinal ganglia and hemorrhages in the CNS (Shen et
al., 1997; Wong et al., 1997). Moreover, in the paraxial
mesoderm of PS12/2 embryos, we observed marked
reductions in the steady-state levels of mRNAs encod-
ing Notch1 and Dll1 (Wong et al., 1997), molecules that
play important roles in differentiation of the presomitic
mesoderm and segmentation of somites (Swiatek et al.,
Figure 1. Expression of the Mouse PrP-Driven huPS1 Transgene in
1994; Conlon et al., 1995; Hrabe de Angelis et al., 1997). E8.5 Embryos
To perform the rescue experiment, we chose a cross- (A) HuPS1 protein is detected in the presomitic mesoderm (PSM)
breeding strategy in which mice expressing either and neural tube (NT) of a huPS1;PS11/1 embryo using an antibody
huPS1 or A246EPS1 transgenes under the transcrip- specific for huPS1. Brackets delineate the somites.
(B and C) Higher-magnification views of the embryo in (A) are showntional control of the mouse prion (PrP) promoter (Bor-
for the neural tube (B) and the presomitic mesoderm (C).chelt et al., 1996; Borchelt et al., 1997) were bred with
(D) No staining is detected in a PS11/1 control littermate.mice heterozygous for PS1 (PS11/2). Resulting offspring,
harboring huPS1 or A246EPS1 transgenes in the PS11/2
background, were then intercrossed to generate prog-
Rescue of PS12/2 Mice by huPS1eny that express huPS1 or the A246E PS1 variant in a
and A246E PS1PS12/2 background. The rescue of PS12/2 phenotypes
We bred two independent transgenic lines (S8±4 andby huPS1 or A246E PS1 is contingent upon expression
R8±1) expressing huPS1 to mice heterozygous for PS1of the PrP promoter±driven PS1 transgene in a spatio-
(PS11/2 mice). Resulting progeny, which harbored thetemporal manner that overlaps the expression of the
huPS1 transgene on a PS11/2 background (huPS1;endogenous murine PS1 gene during embryogenesis.
PS11/2 mice), were intercrossed to generate mice withTo determine the spatial and temporal expression pat-
the huPS1 transgene on a PS12/2 background (huPS1;terns of the huPS1 transgene, transgenic mouse em-
PS12/2 mice). Our previous studies revealed that al-bryos from line S8±4 (Thinakaran et al., 1996) were har-
though the steady-state levels of huPS1 mRNA and full-vested at embryonic day 8.5 (E8.5) or E11.5, and
length protein in brains of S8±4 mice are higher thanexpression of huPS1 was examined by whole-mount
the levels in the mice of the R8±1 line, the accumulatedimmunostaining using a huPS1-specific monoclonal an-
levels of endoproteolytically cleaved PS1 fragments aretibody (Lah et al., 1997; Thinakaran et al., 1996) and in
indistinguishable between these two lines (Thinakaransitu hybridization. AtE8.5, robust huPS1 immunoreactiv-
et al., 1996). As was anticipated from the C. elegansity is detected within the presomitic mesoderm and at
rescue experiments (Levitan et al., 1996; Baumeistermid-level within the neural tube of transgenic embryos
et al., 1997) and the expression pattern of the huPS1(Figures 1A±1C) but not in littermate controls (Figure
transgene in mouse embryos (see above, Figure 1),1D). By E11.5, in situ hybridization analyses revealed
genotyping analysis revealed that the intercross ofthat huPS1 mRNA is detected in the neuroepithelium of
huPS1;PS11/2 mice resulted in viable offspring in whichthe brain and spinal cord in transgenic embryos (data
the huPS1 transgene had rescued the embryonic lethal-not shown). In summary, the spatiotemporal expression
ity of PS12/2 mice.of the huPS1 transgene in embryonic structures that
Genotypes were corroborated by Western blot analy-are prominently affected in PS12/2 mice suggested that
sis of brain extracts from newborn mice using an anti-the huPS1 transgene-encoded human PS1 polypeptide
body (aPS1Loop) that recognizes the PS1 C-terminalmight rescue the developmental phenotypes in mice
lacking PS1. derivative (CTF) of human and mouse PS1. As expected,
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Figure 3. Skeletal Preparations of Alizarin Red± and Alcian Blue±
Stained Neonate Pups
The axial skeletal and rib abnormalities observed in the PS12/2 mice
(b) are absent in both the huPS1 (c) and A246E huPS1 (d) rescued
mice. A nontransgenic control is shown in (a) for comparison.
Figure 2. Levels of PS1 in Brains of Newborn Mice
(A) Total proteins (50 mg) extracted from brains of PS11/1 (lane 1), hybridization analyses revealed that while the steady-
huPS1;PS11/1 (lane 2), A246E;PS12/2 (lane 3), and huPS1;PS12/2 state levels of Notch1 and Dll1 mRNAs are reduced in
(lane 4) mice were analyzed by immunoblot using an anti-PS1Loop
the presomitic mesoderm of PS12/2 embryos (Figures 4aantibody that recognizes the C-terminal fragment of mouse and
and 4d), the expression of these transcripts is restoredhuman PS1 (indicated by arrows).
(B) Ponceau-S stain of blot in (A).
a single PS1-immunoreactive species of z16 kDa is
detected in lysates from nontransgenic mouse brain
(Figure 2, lane 1), while brain extracts from huPS1
transgenic mice (huPS1;PS11/1) revealed two closely
migrating polypeptides of z16 kDa and z17 kDa, repre-
senting the murine and human CTF, respectively. In con-
trast, in brains of mice expressing huPS1 in a PS12/2
background (huPS1;PS12/2), we detected only the hu-
man-specific z17 kDa CTF (Figure 2, lane 4).
In contrast to the PS12/2 mice, which die in late em-
bryogenesis, the huPS1;PS12/2 mice are viable and fer-
tile. In general, their appearance at birth is similar to
siblings with huPS1;PS11/1 and huPS1;PS11/2 geno-
types, without any reduction in body size or shortening
of the tail, phenotypes characteristic of PS12/2 mice.
Importantly, the severe patterning defects of the axial
skeleton and CNS hemorrhage are eliminated in the res-
Figure 4. Restoration of Notch1 and Dll1 Expression in PS12/2-Res-
cued mice. Alcian blue and alizarin red histochemical cued Embryos
staining analyses of the skeletons of two newborn
Detection of Notch1 ([a] through [c]) and Dll1 ([d] and [e]) mRNA by
huPS1;PS12/2 pups revealed that the number, size, and whole-mount in situ hybridization of E9.5 embryos. PS12/2 ([a] and
shape of vertebrae and ribs are identical to control lit- [d]), huPS1;PS12/2 (b), and A246E;PS12/2 ([c] and [e]) embryos are
shown; brackets indicate the presomitic mesoderm.termates (Figures 3a±3c). Moreover, whole-mount in situ
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in huPS1;PS12/2 embryos (Figure 4b). These studies
establish that the PrP promoter±driven human PS1
transgene can rescue the embryonic defects in PS12/2
mice. We have established lines of huPS1;PS12/2 mice
and to date (8 months old) have not observed any abnor-
malities in these animals.
To assess the function of an FAD-linked mutant PS1
during mouse embryogenesis, we bred PS11/2 mice to
one line of transgenic mice that expressed the A246E
PS1 variant (line I2±4). Genotyping of intercrossed prog-
eny revealed that the A246EPS1 transgene successfully
rescued the embryonic lethalityof PS12/2 mice. In brains
of newborn mice with the A246E;PS12/2 genotype, a
single z17 kDapolypeptide corresponding to the human
PS1 CTF was detected by Western blot analysis (Figure
2, lane 3). Alcian blue and alizarin red histochemical
staining of three newborn A246E;PS12/2 mice (Figure
3d) revealed that these animals were indistinguishable
from newborn huPS1;PS12/2 mice. Moreover, we dem-
onstrate that mRNAs encoding Notch1 and Dll1 are ex-
pressed in the presomitic mesoderm of the A246E;
PS12/2 rescued embryos (Figures 4c and 4e), similar
to that observed in huPS1;PS12/2 embryos (Figure 4b).
These results strongly support the view that the FAD-
linked A246E PS1 variant retains sufficient levels of nor-
mal activity during mouse embryonic development.
Ab Levels Are Unchanged in PS11/2 Mice
Expressing Human APP
Figure 5. Determination of PS1 and Ab Levels in PS11/2;APPswe
Although our rescue experiments indicated that the Mice
FAD-linked A246E PS1 variant retains sufficient normal (a) Total SDS-extractable proteins (50 mg) from brains of
activity during embryonic development, it was conceiv- PS11/1;APPswe (1/1) and PS11/2;APPswe (1/2) mice were subject
able that PS1 might possess functional roles after birth to Western blot analysis using aPS1Loop, aPS2Loop, or CT-15 anti-
bodies specific for mouse PS1, PS2, or APP, respectively.quite distinct from those operative during embryogene-
(b) Values of Ab1±42/43 and Ab1±40 are plotted as pmol/g wet brainsis. Moreover, the postnatal activities of PS1 might be
tissue from PS11/1;APPswe (open bar; n 5 8 for 1 month and n 5sensitive to gene dosage. For example, PS1 could play
6 for 5 months) or PS11/2;APPswe (closed bar; n 5 5 for 1 month
a regulatory role in APP trafficking/metabolism and and n 5 3 for 5 months) mice at two different ages as indicated.
thereby modulate the production of Ab peptides during Neither the absolute values of Ab1±42/43 and Ab1±40 nor the ratio
maturation and aging; in this scenario, reduced activity of Ab1±42/43 to Ab1±40 showed any significant differences between
the two groups of mice tested.of FAD-linked variants in adulthood might lead to in-
creased production of Ab1±42/43 peptides. To deter-
mine the effect of reduced PS1 on the levels of Ab1±42/
43, we bred PS11/2 mice to mice expressing a murine of Ab1±40 (Figure 5b) or in the ratio of Ab1±42/43 to
Ab1±40 (data not shown) in these mice. Thus, reducingPrP-driven chimeric APPswe transgene (Borchelt et al.,
1996). We confirmed that in 1-month-old APPswe;PS11/2 the level of murine PS1 to z50% is insufficient to alter
the levels of Ab1±42/43 peptides. In contrast, we andmice, the levelof PS1 is z50% of thenormal level (Figure
5a), consistent with our earlier immunoblot analyses of others have documented that expression of FAD-linked
mutant PS1 variants increases the steady-state levelsPS11/2 mice (Wong et al., 1997). Moreover, these data
support our earlier conclusion that the levels of PS1 de- of Ab1±42/43 peptides (Borchelt et al., 1996; Duff et al.,
1996; Scheuner et al., 1996; Citron et al., 1997). Hence,rivatives are highly regulated; in the case of APPswe;
PS11/2 (or PS11/2) mice, the synthesis and degradation the mechanism(s) by which FAD-linked mutant PS1
causes disease is unlikely to result from reduction ofrates of PS1 polypeptides are balanced so that accumu-
lation is z50%of wild-type levels. Finally, we used quan- wild-type PS1 levels during aging but rather from eleva-
tion of the extracellular concentration of highly fibrillo-titative sandwich ELISA assays to measure the levels
of Ab peptides in brain homogenates from 1- and genic Ab1±42/43 peptides, leading to Ab deposition
(Borchelt et al., 1997).5-month-old APPswe;PS11/2 mice. We observed that
the average levels of Ab1±42/43 in these animals at 1
and 5 months of age were 1.8 6 0.13 and 2.1 6 0.15 Discussion
pmol/g, respectively, values that are nearly indistin-
guishable from the levels in brains of PS11/1 mice ex- The mechanism(s) by which PS1 mutants cause FAD
are not fully established. All but one of the mutations inpressing APPswe (Figure 5b). Similarly, we failed to ob-
serve any significant differences in the absolute levels PS1 identified to date encode missense substitutions;
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the notable exception is a splice acceptor mutation that PS11/2 mice are no different from those of PS11/1 mice;
hence, simple reduction in the level of wild-type PS1 isleads to an in-frame deletion of exon 9 (29 amino acids).
Large truncation or frameshift mutations that would unlikely to account for FAD-linked PS1variant±mediated
elevations in Ab1±42/43 levels.functionally disable PS1 have not been described and
argue against the hypothesis that reduced PS1 function Despite our demonstration that the A246E PS1 variant
retains levels of normal activity sufficient to rescue theunderlies the pathogenesis of PS1-linked FAD. Indeed,
an invariant feature of autosomal dominant disorders in phenotypic alterations and embryonic lethality associ-
ated with the loss of PS1 in mouse, we are left with thewhich reduced levels of the functional gene product
lead to developmental or age-associated phenotypes is conundrum that the A246E PS1 variant only partially
rescues the Egl defect in C. elegans lacking sel-12. Thethe presence of chromosomal deletions. For example,
deletions in genes encoding elastin, CREB protein, and difference in rescue activity of the A246E PS1 variant
in different experimental paradigms could reflect theJagged 1 lead to autosomal dominant diseases, namely
Williams syndrome (Nickerson et al., 1995), Rubinstein- sensitivity of each assay system. For example, it is con-
ceivable that overexpression of huPS1 transgenes inTaybi syndrome (Petrij et al., 1995), and Alagille syn-
drome (Li et al., 1997; Oda et al., 1997), respectively. In mice masks subtle differences in the rescue efficiency
between wild-type and mutant PS1. Resolution of thiscontrast to these disorders associated with haploinsuffi-
ciency, we have failed to detect any obvious develop- issue will require examination of mice expressing sub-
saturating levels of wild-type and mutant human PS1mental deficiencies in PS11/2 mice. Hence, even if a
mutant form of PS1 in patients with PS1-linked FAD on a PS12/2 background. Nevertheless, in both the C.
elegans and mouse rescue paradigms, FAD-linked mu-exhibited reduced function during development, it is
highly unlikely that diminished activity would lead to tant PS1 retains some level of normal function during
development.developmental abnormalities or account for the pheno-
typic consequences in the adult. In conclusion, ourdemonstration that theAb1±42 pep-
tide levels in brains of mice heterozygous for PS1 areIn the absense of a biochemical test for PS1 functions,
we and others chose to assess the ability of wild-type unchanged relative to their wild-type controls strongly
suggests that mutant PS1±mediated increases in Ab1±42and mutant human PS1 to rescue an Egl defect in C.
elegans lacking the PS homolog, sel-12 (Levitan et al., peptides are unlikely due to loss of presenilin ªactivityº
during aging. Despite the strengths of these conclu-1996; Baumeister et al., 1997). In contrast to wild-type
human PS1, which completely rescued the Egl pheno- sions, the molecular mechanisms that underlie PS1 vari-
ant±mediated influences on APP processing and Ab1±type, six independent FAD-linked PS1 variants exhibited
reduced rescue activity in nematodes. These observa- 42/43 production have been elusive. Future efforts
aimed at identifying (1) the interactions of PS with cellu-tions are compatible with the view that mutant PS1 may
cause AD as a result of diminished PS1 function(s). In lar components that mediate its normal function during
development and in aging, (2) the influence of PS1 oncontrast, investigations in cultured mammalian cells and
the subcellular localization of ªg-secretaseº activitiestransgenic mice have convincingly demonstrated that
responsible for generating the Ab1±42/43 termini, andmutant, but not wild-type, human PS1 influences APP
(3) the role of PS1 in APP/Ab trafficking will be criticalprocessing in a manner that increases the extracellular
for elucidating the complex regulation of Ab1±42/43 pro-concentration of highly amyloidogenic Ab1±42/43 pep-
duction by mutant PS.tides; these findings were interpreted to suggest that
mutant PS1causes AD by enhancement of a constitutive
Experimental Proceduresactivity or by the gain of deleterious propert(ies) (Bor-
chelt et al., 1996, 1997; Duff et al., 1996; Scheuner et
Generation of Mice Expressing Human PS1
al., 1996; Citron et al., 1997). To try to reconcile these in PS12/2 Background
apparently dichotomous interpretations, we employed Transgenic mice expressing human wild-type (lines S8±4 and R8±1)
two strategies: first, we asked whether the embryonic and mutant A246E (line I2±4) PS1 have been described (Borchelt et
al., 1996; Thinakaran et al., 1996; Lee et al., 1997). To generate micelethality in mice lacking PS1 could be rescued by wild-
that express either human wild-type or A246E PS1 in the PS12/2type or mutant human PS1; and second, we examined
background, we cross-bred human wild-type or mutant PS1 micethe levels of Ab peptides in brains of mice with a 50%
to heterozygous PS1 null (PS11/2) mice initially to generate a small
reduction in absolute levels of PS1. cohort of PS11/2 mice expressing human wild-type or A246E PS1.
In this report, we demonstrate that the murine PrP Subsequently, PS11/2 mice expressing human wild-type or A246E
promoter±driven huPS1 transgene is expressed during PS1 were intercrossed to generate offspring that express human
wild-type or A246E PS1 in the PS12/2 background. Genotypes wereembryogenesis and in a spatiotemporal manner that
determined by PCR amplification of tail DNA. One primer set (59resembles the murine PS1 gene. Hence, it was not unex-
CAGGTGGTGGAGCAAGATG; 59 CCTCTTTGTGACTATGTGGACTGpected that expression of wild-type human PS1 could
ATGTCGG; 59 GTGGATACCCCCTCCCCCAGCCTAGACC) was used
efficiently rescue the embryonic lethality and associated to detect the human wild-type or A246E PS1 as previously described
morphological phenotypes of PS12/2 animals. More im- (Thinakaran et al., 1996) and anotherprimer set (59 CCATTGCTCAGC
GGTGCTG; 59AGCCAAGAACGGCAGCAGCAGCATGACAGGCAGAG;portantly, we document that the rescue activity of the
59 CTTCCATGAGCCATTTGCTAAGTGC) was used to detect the tar-FAD-linked A246E PS1 variant is essentially indistin-
geted PS1 allele (Wong et al., 1997).guishable from that of wild-type human PS1. These re-
sults strongly suggested that the FAD-linked A246E PS1
Generation of PS11/2 Mice Expressing
variant retained the normal PS1 function(s) required for Human APPswe
embryonic development. Finally, we demonstrated that Transgenic mice expressing human APPswe were previously de-
scribed (Borchelt et al., 1996). One line (Q2±2), which was bred tothe levels of Ab1±42/43 or Ab1±40 peptides in brains of
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homozygosity, was crossbred to PS11/2 mice to generate PS11/2 Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis ele-
gans Notch signaling independently of proteolytic processing.mice expressing human APPswe or mice expressing human
APPswe in a PS11/1 background. Genotyping for the PS1 targeted Genes Funct. 1, 149±159.
allele was carried out as described above. Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport,
F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et
al. (1996). Familial Alzheimer's disease-linked presenilin 1 variantsWhole-Mount Immunostaining
elevate Ab1±42/1±40 ratio in vitro and in vivo. Neuron 17, 1005±1013.and In Situ Hybridization
Embryos were collected on E8.5 from matings between male human Borchelt, D.R., Ratovitski, T., van Lare, J., Lee, M.K., Gonzales, V.,
PS1 transgenic mice and C3B6 female nontransgenic mice. Embry- Jenkins, N.A., Copeland, N.G., Price, D.L., and Sisodia, S.S. (1997).
onic staging was determined by timed pregnancies, with the morn- Accelerated amyloid deposition in the brains of transgenic mice
ing that the vaginal plug was observed designated as day E0.5. coexpressing mutant presenilin 1 and amyloid precursor proteins.
Embryos were fixed andstored as described(Davis andReed, 1996). Neuron 19, 939±945.
Embryos were rehydrated and blocked as described (Sundin and Campion, D., Flaman, J.M., Brice, A., Hannequin, D., Dubois, B.,
Eichele, 1992) and incubatedwith a rat monoclonalantibody specific Martin, C., Moreau, V., Charbonnier, F., Didierjean, O., Tardieu, S.,
for human PS1 at a 1:2000 dilution. Embryos were washed, incu- et al. (1995). Mutations of the presenilin 1 gene in families with early
bated in biotinylated rabbit anti-rat IgG (Vector) at a 1:200 dilution, onset Alzheimer's disease. Hum. Mol. Genet. 4, 2373±2377.
washed again, and finally incubated overnight at room temperature
Chapman, J., Asherov, A., Wang, N., Treves, T.A., Korczyn, A.D.,with an avidin±biotin±horseradish peroxidase complex according to
and Goldfarb, L.G. (1995). Familial Alzheimer's disease associatedthe manufacturer's instructions (Vectastain Elite ABC kit; Vector
with S182 codon 286 mutation. Lancet 346, 1040.Labs, Burlingame, CA). Immunoreactivity was visualized with a per-
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A.,oxidase substrate kit according to the manufacturer's instructions
Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J.,(Vector Labs, Burlingame, CA).
and Mullan, M. (1991). Early onset Alzheimer's desease caused byIn situ hybridization of whole-mount mouse embryos with RNA
mutations at codon 717 of the b-amyloid precursor protein gene.probes was performed as described (Hogan et al., 1994). Linearized
Nature 353, 844±846.plasmids containing sequences specific for Notch1 or Dll1 were
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque,used as a template for in vitro transcription using the digoxigenin
G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997).RNA labeling kit (Boehringer Mannheim).
Mutant presenilins of Alzheimer's disease increase production of 42-
residue amyloid b-protein in both transfected cells and transgenicProtein Blot Analysis
mice. Nature Med. 3, 67±72.Detergent (2% SDS) lysates were prepared from brains of newborn
Conlon, R.A., Reaume, A.G., and Rossant, J. (1995). Notch1 is re-or 1-month-old mice, and 50 mg aliquots were fractionated on SDS-
quired for the coordinate segmentation of somites. Developmentpolyacrylamide gel, blotted with an aPS1Loop antisera (1:1000 dilu-
121, 1533±1545.tion; Thinakaran et al., 1996) or an aPS2Loop antisera (1:1000
Cruts, M., Hendriks, L., and Van Broeckhoven, C. (1996). The pre-dilution; Thinakaran et al., 1996). Bound primary antibodies were
senilin genes: a new gene family involved in Alzheimer's diseasevisualized with Protein A-HRP (Sigma, St. Louis, MO) and enhanced
pathology. Hum. Mol. Genet. 5, 1449±1455.chemiluminescence (Amersham) following previously described
methods (Thinakaran et al., 1997). Davis, J.A., and Reed, R.R. (1996). Role of Olf-1 and Pax-6 transcrip-
tion factors in neurodevelopment. J. Neurosci. 16, 5082±5094.
Skeletal Staining Duff, K., Eckman, C., Zehr, C., Yu, X., Prada,C., Perez-tur, J., Hutton,
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